SELTZER REUBEN 4
4 · HI TECH PHARMACAL CO INC · Filed Oct 18, 2012
Insider Transaction Report
Form 4
SELTZER REUBEN
Director10% Owner
Transactions
- Sale
Common Stock
2012-10-16$32.56/sh−6,800$221,408→ 521,160 total - Sale
Common Stock
2012-10-15$33.47/sh−3,200$107,104→ 527,690 total
Holdings
- 276,250
Stock Option (Right to Buy)
→ Common Stock (276,250 underlying) - 300,108(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.36 to $33.63, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1) and (2) of this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.41 to $33.08, inclusive.
- [F3]Stock Options granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
- [F4]Mr. Seltzer is also the holder of options to acquire an aggregate 276,250 shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.